New real-world data support long-term efficacy and safety profile of MAVENCLAD
Merck, a leading science and technology company, announced the presentation of new data for MAVENCLAD® (cladribine tablets), which further characterise
A forum for researchers, students and applicants in the field of cyclodextrin technology
Merck, a leading science and technology company, announced the presentation of new data for MAVENCLAD® (cladribine tablets), which further characterise